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NONLINEAR INTERFEROMETRIC	 1.5 microns. Therefore multiphoton nonlinear processes need
VIBRATIONAL IMAGING
	
	
to be employed to probe these resonances. The photons to
stimulate and record the processes are typically in a region
CROSS REFERENCE TO RELATED	 where the tissue is not absorbing, so that they can reach the
APPLICATIONS	 5 tissue feature and be measured from the feature.
Raman spectroscopy, first discovered in 1928, uses
The present application claims priority to U.S. Provisional 	 molecular resonance features of frequency Aw to split a pho-
application 60/442,300, filed Jan. 24, 2003, which is hereby 	 ton of frequency co into another photon of frequency w—Aw
incorporated by reference.
	
	 and a resonance excitation of frequency Aw. The presence of
io photons at frequency w—Aw identifies the concentration of the
FEDERALLY SPONSORED RESEARCH OR	 resonance feature. This process is in practice very weak and
DEVELOPMENT	 requires large amounts of power to produce any detectable
amounts of photons. This weakness is due to the fact that the
The subject matter of this application may in part have been	 probability of a Raman excitation process to occur is propor-
funded by the NASA/National Cancer Institute (Contract no. 15 tional to the number of photons at frequency w—Aw already
NAS2-02057). The government may have certain rights in	 present, of which there are typically few or none. Since pho-
this invention.	 tons that would be emitted by Raman excitation at frequency
w—Aw are indistinguishable from the incoming radiation that
BACKGROUND	 stimulates them, this is not a viable technique for achieving
20 molecular sensitivity.
The ability to measure the three-dimensional structure of 	 Coherent Anti-Stokes Raman Scattering (CARS) is
biological tissues is important, but common methods used to 	 another nonlinear spectroscopy technique that unlike conven-
leave out basic information about the molecular composition	 tional Raman spectroscopy, allows all of the photons neces-
and metabolic behavior of the tissue imaged. This molecular 	 sary to stimulate the process to be introduced into the tissue
composition and metabolic behavior information may yield 25 by the illuminating source. This enables the probability of a
valuable scientific data on the behavior of biological systems, 	 CARS interaction to be increased to a (theoretically arbi-
and would be of great clinical diagnostic value for finding 	 trarily) high level so that a sufficient number of photons can
diseases such as cancer. Much of the focus of biological and 	 be produced as to enable detection within a reasonable time
medical imaging today is to gain information about compo-	 period. It is essentially two stimulated Raman scattering pro-
sition.	 30 cesses in parallel. Two photons, a "pump" of frequency w,
Functional magnetic resonance imaging (FMRI) utilizes 	 and a "Stokes" of frequency w z illuminate the tissue. They
contrast agents specific to particular molecular species or 	 must be separated in frequency by w i
—W 2=Aw, which is the
metabolic processes to provide specific information about the 	 frequency of the molecular resonance. When molecules of the
three-dimensional (3-D) location of these species or pro- 	 target molecular species are present, the resonance will be
cesses. This method is quite versatile, and poses relatively 35 excited, and the pump photon will be converted to the same
little risk to the patient, but is limited in practice to a resolu-	 frequency as the Stokes photon. This is the first stimulated
tion over 100 microns. Positron Emission Tomography (PET) 	 Raman scattering process. Another photon may arrive at fre-
and Single Photon Emission Computed Tomography	 quency w3 that will stimulate the emission of the excitation
(SPECT) utilizes a radiolabeled metabolic molecule to pro-	 from the resonance, so that the energy of the photon of fre-
vide 3-D measurements of utilization of these molecules by 4o quency w4 and the excitation are converted to a new photon of
sensing their gamma-ray emissions. Unfortunately, these 	 frequency w4 w3 +Aw, called the "anti-Stokes" photon. The
methods have been cost prohibitive as diagnostic tools, and 	 presence of this photon of frequency w 4 indicates that a
expose the patient to ionizing radiation. Fluorescence micros- 	 CARS process has taken place and indeed a molecule with the
copy labels relevant biological structures and processes with 	 resonance feature is present. Often the "pump" beam is used
a fluorescent compound which can be measured by conven- 45 as the photons of frequency w 3, so that w, —w, and w4 2w i -
tional microscopy or confocal microscopy. The two-photon 	 wz . Since the photon of w4 is not the same frequency as one of
variant uses ultrafast pulses so that emission and excitation 	 the illuminating photons, and is typically within the transpar-
frequencies can be clearly separated, and also utilizes the	 ency range of the tissue, it is easily discriminated from the
additional selectivity that the intensity-sensitive nature of	 incoming radiation. FIG. 1A shows an energy-level diagram
two-photon excitation provides. While some biological struc-  50 for CARS, and FIG. 1B shows an energy-level diagram for
tures produce natural fluorescence, in general externally 	 Coherent Stokes Raman Scattering.
introduced fluorescence markers must be used, which can	 CARS microscopy uses the CARS process to look for the
interfere with biological processes and are often toxic. 	 presence of a molecular species, but does not require any
Molecules frequently have molecular resonance frequen- 	 foreign substances to be introduced into the tissue. It scans the
cies that are due to the electromagnetic attractions of atoms in 55 illumination point-by-point through the tissue and measures
the molecule. These frequencies are those of molecular vibra- 	 the number of generated anti-Stokes photons. When a three-
tions, molecular rotational motions, the excitation of elec- 	 dimensional mesh of points has been scanned, a complete
trons to higher energy states, and occasionally finer structures	 three-dimensional picture of molecules of that resonance can
such as hyperfine interactions and optical-magnetic proper- 	 be shown. Since CARS is a nonlinear process (and therefore
ties. These properties are present without the introduction of 60 is intensity sensitive), efficient conversion only occurs at the
any external contrast molecule. These frequencies are usually 	 focus of the illumination, which can be made very tight (typi-
in the mid-infrared, corresponding to photons of 1.5-50 	 cally a half micron in both the axial and lateral directions).
microns of wavelength. Unfortunately, they cannot be 	 Therefore the resolution can be made many orders of magni-
directly excited by electromagnetic radiation of the same 	 tude better than MRI, which is the probably the largest com-
frequency because when they are in tissue, the surrounding 65 petition for clinical use for similar purposes. Unfortunately,
water absorbs almost all of these frequencies. The range of 	 the penetration is usually rather low (limited to about 500
wavelengths that the tissue is relatively transparent to is 0.6- 	 microns). A further shortcoming is that CARS microscopy
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measures the total number of anti-Stokes photons, or power, 	 oped to enable internal body OCT imaging [39,40]. Most
from the sample. However, the optical field contains temporal 	 recently, OCT has been combined with catheter-endoscope-
structure in the phase that is averaged out by power detection	 based delivery to perform in vivo imaging in animal models
because photodetector response time is orders of magnitude 	 and human patients [41-44].
slower than the oscillations of the optical field. The time scale 5	 Apart from medical applications, OCT has been demon-
on which the optical pulse varies (which is typically picosec- 	 strated as an emerging investigational tool for cell and devel-
onds or femtosecond time scales) is far too fast for photon	 opmental biology. OCT has imaged the development of
detection equipment or electronics to detect (the fastest of 	 numerous animal models including Rana pipiens and Xeno-
which may detect 25 ps time scales). 	 pus laevis (Leopard and African frog), andBrachydanio rerio
Optical coherence tomography (OCT) is an emerging io (zebrafish) [45-46]. High-speed OCT imaging has permitted
high-resolution medical and biological imaging technology 	 the morphological and functional imaging of the developing
[15-21]. OCT is analogous to ultrasound B-mode imaging 	 Xenopus cardiovascular system, including changes in heart
except reflections of low-coherence light are detected rather 	 function following pharmacological interventions [47].
than sound. OCT detects changes in the backscattered ampli- 	 High-resolution imaging has permitted the real-time tracking
tude and phase of light. 	 15 of cell dynamics in living specimens including mesenchymal
Cross-sectional OCT imaging is performed by measuring 	 cell mitosis and neural crest cell migration [48]. OCT is
the backscattered intensity of light from structures in tissue. 	 advantageous in microscopy applications because repeated
This imaging technique is attractive for medical imaging	 non-invasive imaging of the morphological and functional
because it permits the imaging of tissue micro structure in situ, 	 changes in genetically modified animals can be performed
yielding micron-scale imaging resolution without the need 20 overtime without having to histologically process multiple
for excision and histological processing. Because OCT per- 	 specimens. The high-resolution, cellular-imaging capabili-
forms imaging using light, it has a one- to two-order-of-	 ties suggest that OCT can be used to diagnose and monitor
magnitude higher spatial resolution than ultrasound and does 	 early neoplastic changes in humans.
not require contact with tissue. 	 The ability of OCT to perform optical biopsies, the in situ
OCT was originally developed and demonstrated in oph- 25 imaging of tissue microstructure at near-histological resolu-
thalmology for high-resolution tomographic imaging of the 	 tion, has been used to image morphological differences
retina and anterior eye [22-24] . Because the eye is transparent 	 between normal and neoplastic tissue. OCT images of in vitro
and is easily optically accessible, it is well-suited for diag- 	 neoplasms of the female reproductive tract [49], the gas-
nostic OCT imaging. OCT is promising for the diagnosis of 	 trointestinal tract [50], and the brain [51] have been investi-
retinal diseasebecause it canprovide images ofretinal pathol- 30 gated. Optical differences between normal and neoplastic
ogy with 10 M resolution, almost one order-of-magnitude	 tissue were evident, but primarily for late-stage changes. Still,
higher than previously possible using ultrasound. Clinical 	 situations exists were no inherent optical contrast exists
studies have beenperformed to assess the application of OCT	 between normal and pathologic tissue, such as in early-stage,
for a number of macular diseases [23,24]. OCT is especially	 pre-malignant tumors or in tumors which remain optically
promising for the diagnosis and monitoring of glaucoma and 35 similar to normal tissue.
macular edema associated with diabetic retinopathy because 	 In the past, OCT has found numerous medical and biologi-
it permits the quantitative measurement of changes in the	 cal applications. However, the imaging technique has relied
retinal or retinal nerve fiber layer thickness. Because morpho- 	 largely on the inherent optical properties of the tissue to
logical changes often occur before the onset of physical 	 provide contrast and differentiate normal from pathological
symptoms, OCT can provide a powerful approach for the 40 tissue. Phospholipid-coated perfluorobutane microbubbles
early detection of these diseases. 	 (ImaRx Pharmaceutical, Tucson, Ariz.) have been used as a
Recently, OCT has been applied for imaging a wide range	 contrast agent for OCT; although they produce a strong OCT
of nontransparent tissues [16,17,25-27]. In tissues other than 	 signal, blood and tissue also produce a fairly strong OCT
the eye, the imaging depth is limited by optical attenuation 	 signal, and the effects of this contrast agent in vivo on the
due to scattering and absorption. A "biological window" 45 visualization of blood vessels are subtle.
exists in tissue where absorption of near-infrared wave-
lengths is at a minimum and light can penetrate deep into	 SUMMARY OF THE INVENTION
highly-scattering tissue (FIG. 15) [28]. Because optical scat-
tering decreases with increasing wavelength, OCT in non- 	 In a first embodiment, the invention provides a method of
transparent tissues has routinely used 1.3 µm wavelength 50 examining a sample, which includes: exposing a reference to
light for imaging. In most tissues, imaging depths of 2-3 mm	 a first set of electromagnetic radiation, to form a second set of
can be achieved using a system detection sensitivity of 110 dB 	 electromagnetic radiation scattered from the reference;
(1 part in 10"). OCT has been applied to image arterial 	 exposing a sample to a third set of electromagnetic radiation
pathology in vitro and has been shown to differentiate plaque 	 to form a fourth set of electromagnetic radiation scattered
morphology with superior resolution to ultrasound [17,29]. 55 from the sample; and interfering the second set of electro-
Imaging studies have also been performed to investigate 	 magnetic radiation and the fourth set of electromagnetic
applications in gastroenterology, urology, and neurosurgery 	 radiation. In this embodiment, the first set and the third set of
[30-32]. High resolution OCT using short coherence length,	 electromagnetic radiation are generated from a source. More-
short-pulse light sources, has also been demonstrated and 	 over, at least a portion of the second set of electromagnetic
axial resolutions of less than 5 µm have been achieved [33, 6o radiation is of a frequency different from that of the first set of
34]. High-speed OCT at image acquisition rates of 4 to 8 	 electromagnetic radiation, and at least a portion of the fourth
frames per second for 500 to 250 square pixel images has 	 set of electromagnetic radiation is of a frequency different
been achieved [35]. OCT has been extended to perform Dop- 	 from that of the third set of electromagnetic radiation.
pler imaging of blood flow and birefringence imaging to 	 In a second embodiment, the invention provides a method
investigate laser intervention [36-38]. Different imaging 65 of forming an image of a sample, which includes: exposing a
delivery systems including transverse imaging catheters and	 reference to a first set of electromagnetic radiation, to form a
endoscopes, and forward imaging devices have been devel-	 second set of electromagnetic radiation scattered from the
US 7,623,908 B2
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reference; exposing a sample to a third set of electromagnetic 	 FIG. 11. Temporal cross-correlator for a serial-point scan-
radiation to form a fourth set of electromagnetic radiation 	 ning microscope.
scattered from the sample; forming a digital data set corre- 	 FIG. 12. Shown are two configurations that utilize linear
sponding to the sample; and converting the data set into an	 photodetector arrays to measure multiple samples of the
image. In this embodiment, the data set is formed by interfer-  5 cross-correlation simultaneously.
ing the second set of electromagnetic radiation and the fourth 	 FIG. 13. Diagram of an implementation of the recorder.
set of electromagnetic radiation. Also, the first set and the 	 FIG. 14. Electrical cross-correlation signal quadrature
third set of electromagnetic radiation are generated from a	 amplitude demodulator.
source. Moreover, at least a portion of the second set of 	 FIG. 15. `Biological window" in tissue where absorption
electromagnetic radiation is of a frequency different from that io of near-infrared wavelengths is at a minimum and light can
of the first set of electromagnetic radiation, and at least a 	 penetrate deep into highly-scattering tissue.
portion of the fourth set of electromagnetic radiation is of a
frequency different from that of the third set of electromag- 	 DETAILED DESCRIPTION
netic radiation.
In a third embodiment, the invention provides a device for 15	 Nonlinear interferometric vibrational imaging (NIVI) is a
examining of a sample having an oscillator, a reference gen- 	 method used to measure the three-dimensional distribution of
erator that is optically coupled to the oscillator, a microscope 	 molecular species in various samples (biological or other-
that is optically coupled to the oscillator, a demodulator that	 wise). Its basic operation is to stimulate the excitation of
is optically coupled to the reference generator and the micro- 	 molecular bonds with particular resonance frequencies, and
scope, and a recorder that is coupled to the demodulator. 	 20 then use these excitations to produce radiation distinct from
In a fourth embodiment, the invention provides a method of
	 the excitation that can be measured. The physical process of
examining a sample that includes exposing a sample to a first	 excitation and stimulation of radiation is called Coherent
set of electromagnetic radiation to form a second set of elec- 	 Anti-Stokes Raman Scattering (CARS). Unlike previous
tromagnetic radiation scattered from the sample, and inter-	 methods that use CARS in microscopy to probe for the pres-
fering the second set of electromagnetic radiation with a third 25 ence of molecular species, NIVI utilizes a heterodyne
set of electromagnetic radiation. In thi s embodiment, the third	 approach where areference signal is separately generated and
set of electromagnetic radiation is phase-coherent with the 	 interferomerically compared to the signal received from the
first set of electromagnetic radiation, at least a first portion of	 sample, allowing the signal to be formed into an image in the
the second set of electromagnetic radiation is of a frequency 	 same way as OCT. In this way, additional information can be
different from that of the first set of electromagnetic radiation, 30 inferred from the emitted radiation such as the distance to the
and at least a portion of the third set of electromagnetic 	 sample and phase information that yields additional structure
radiation is of the same frequency as the first portion of the 	 of the molecular bonds. It also has other advantages in sen-
second set of electromagnetic radiation. 	 sitivity and the ability to screen out background radiation that
In a fifth embodiment, the invention provides a method of
	 is not produced by the sample. It also can allow more flex-
forming an image of a sample that includes exposing a sample 35 ibility in the choice of laser illumination source, because the
to a first set of electromagnetic radiation to form a second set	 coherent detection process does not rely on photon frequency
of electromagnetic radiation scattered from the sample, form- 	 alone to discriminate emitted radiation.
ing a digital data set corresponding to the sample, and con- 	 The term "scattered photon" means photons scattered by a
verting the data set into an image. In this embodiment, the 	 sample, which include linearly scattered photons and non-
forming of the image includes interfering the second set of 40 linearly scattered photons, such as CARS and CSRS photons.
electromagnetic radiation and a third set of electromagnetic 	 The term "image" means data produced by receipt of elec-
radiation. Moreover, the third set of electromagnetic radiation 	 tromagnetic radiation, which may or may not be formed into
is phase-coherent with the first set of electromagnetic radia- 	 a picture viewable by the human eye. This includes images
tion. In addition, at least a first portion of the second set of	 produced directly onto a medium such as film or video.
electromagnetic radiation is of a frequency different from that 45	 The phrase "frequency range of infra-red to ultraviolet'
of the first set of electromagnetic radiation, and at least a 	 means electromagnetic radiation having a frequency of 1012
portion of the third set of electromagnetic radiation is of the 	 to 10" Hz, which excludes radio waves, microwaves, X-rays
same frequency as the first portion of the second set of elec- 	 and gamma rays. The term "light' means visible light.
tromagnetic radiation.	 The method of NIVI was developed at first because CARS
50 microscopy based on non-interferometric detection is incom-
BRIEF DESCRIPTION OF THE DRAWINGS 	 patible with the scanning modes of OCT. When the method of
CARS microscopy is employed, information about the echo
FIG. 1. Coherent Anti-Stokes Raman Scattering and	 time of the optical signal is lost because the photodetector is
Coherent Stokes Raman Scattering energy-level diagrams. 	 not nearly fast enough to respond to the relatively instanta-
FIG. 2. Basic block diagram of NIVI	 55 neous return of the return pulse. In OCT a reference wave is
FIG. 3. Example laser configurations are shown that pro- 	 used so that the relative time delay between the reference
duce two pulses of frequencies w, and w z overlapped. We	 wave and the returned echo wave can be determined. Nonlin-
assume that the delays have been set correctly to overlap 	 ear methods (such as conventional Raman spectroscopy) are
them.	 unsuited to integration with OCT because the emitted signal
FIG. 4. Methods of shaping a broadband pulse into a pulse 60 is incoherent with respect to the excitation. However, CARS
with beat frequency Aw.	 processes preserve coherence, and therefore enable interfero-
FIG. 5. Reference Signal Generator Implementation	 metric methods to be used. By using a nonlinearly generated
FIG. 6. Configurations for full field CARS.	 reference wave, the time of arrival of a CARS signal returning
FIG. 7. Translated serial-point scanning configurations 	 from the tissue can be interferometrically compared to the
FIG. 8. Beam-steered serial-port scanning configurations 65 arrival time of the reference signal. In this way, the methods of
FIG. 9. Temporal-ranging based NIVI 	 OCT and CARS imaging can be integrated. In addition, in a
FIG. 10. Full field cross-correlator demodulator 	 manner analogous to how OCT can measure the dispersion of
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scatterers in the medium, NIVI can measure the dispersion of 	 Each of these units will be detailed presently.
the response of molecules to the excitation radiation. This is 	 1. Oscillator.
because NIVI measures the relative phase between the refer- 	 The oscillator produces the electromagnetic field that
ence signal and the sample signal. This dispersion should 	 stimulates the excitation of the resonance to be probed. It also
contain information about the resonance structure of the mol- 5 provides the photon that stimulates the output photon that is
ecule over and above what can be measured using CARS 	 detected as evidence of CARS or CSRS. There are many
microscopy.
	
	 types of oscillators and fields that can produce CARS. Each
pulse produced by the oscillator should be nearly identical so
The Nonlinear Interferometric Vibrational Imaging 	 that it can excite consistent signals in the reference generator
Method
	
	 io and sample. If the oscillator produces too variable of a signal,
the signals from the reference generator and sample may
The purpose of NIVI is to measure the temporal field	 change and produce signals that can be confused with noise
radiated by samples that are stimulated using the CARS tech- 	 sources. Variability in the oscillator output is a noise source in
nique. When the field is scanned through the sample, an 	 itself that adds uncertainty to what the expected demodulated
image can be formed of the molecular contents of the sample. 15 signal should be.
As illustrated in FIG. 2, a preferred embodiment NIVI 200	 The conventional way to produce CARS is to send in two
has the following components: 	 overlapped optical pulses, one of which at frequency w i , the
Oscillator. This oscillator 201 produces an optical field that 	 pump, and the other at w 2, the Stokes pulse, where
can excite the resonance mode of the target molecule through 	 w i
—W2=Aw, where Aw is the resonance frequency of the
a nonlinear technique (usually stimulated Raman scattering), 20 molecules of interest. These pulses produce a beat frequency
and also the photon to stimulate the photon that is measured 	 of Aw that manifests itself in the magnitude of the optical
(also usually through stimulated Raman scattering). The	 field. In linear time-independent optics, systems are sensitive
combination of these processes is called CARS. 	 only to the frequencies of the optical pulses themselves, and
Reference Generator. The reference signal generator 203, 	 not any beats they may produce together. However, with
which can sometimes be incorporated into the oscillator, con- 25 sufficient intensity the intensity envelope may itself stimulate
verts part of the oscillator signal to a reference signal that can 	 the molecule. By choosing two pulses that produce beats of
be used in the demodulator section. It acts as a known signal 	 this frequency, we can stimulate the molecule with two wave-
that demodulates the unknown signal from the sample in the 	 lengths that the tissue is transparent to. Once the resonance is
interferometer. 	 stimulated, another photon of frequency w, (in CARS), or of
Microscope. The microscope 205 delivers the field pro- 30 frequency w2 (in CSRS) stimulates the emission of a fourth
duced by the oscillator to the sample, and collects the field 	 photon, which is of frequency 2w,—w 2 for CARS, and 2w 2-
emitted by the sample. The excitation field is usually deliv-	 co, for CSRS.
ered by a microscope objective, where the oscillator field is 	 Systems that can be used to produce these two frequencies
focused tightly or sparsely, depending on the scanning 	 are shown below in FIG. 3. A common configuration to pro-
method. This focus is scanned through the tissue, and based s y duce pulses of these two wavelengths that are overlapped in
on the signal received from each tissue volume an image can	 time is to have a pulsed laser produce one of these wave-
be formed. When the oscillator signal is delivered to the tissue 	 lengths, split off of some of its energy, and use this energy to
containing a molecule with a compatible resonance, a non-	 produce a second pulse of a lower or higher frequency. In one
linear process such as CARS can occur and produce a new 	 configuration 300, a pump laser 301 pumps a dye laser 303,
sample signal (called the "anti-Stokes" for CARS processes). 40 for example a doubled Nd:YAG pump laser at 532 nm pump-
This sample signal serves as an indicator of the presence of 	 ing a tunable dye laser. In another possible configuration 302,
the molecular resonance, and also provides additional infor-	 a pump laser such as a Ti-sapphire oscillator pumps an optical
mation about the molecule through the temporal structure of	 parametric oscillator (a device that converts pulses to lower
the sample signal. 	 frequencies) 305.
Demodulator. The demodulator 207 combines the signal 45 In yet another configuration 304, the pump laser pumps a
received from the sample with the reference signal. This is 	 regenerative amplifier 307, such as a Ti-sapphire regenerative
typically achieved by constructing an interferometric cross- 	 amplifier. The regenerative amplifier then pumps an optical
correlator. The cross-correlation of the two signals is then 	 parametric amplifier (another frequency conversion device)
measured by a single photodetector or array of photodetec- 	 309. Alternatively, as illustrated in configuration 306, the
tors. The power received by these photodetectors allows the 50 pulses of each wavelength are generated by two separate
cross-correlation signal to be inferred, from which the tem-	 pump lasers, and the time overlap is maintained by a circuit
poral response signal from the sample can be also inferred.	 311 that synchronizes the two sources. In another configura-
With knowledge of the physics of the molecule, the presence 	 tion 308, the pump laser pumps a continuum light generator
of and potentially properties of the molecule being tested can 	 313, generating broadband light whichis filtered by a filter for
be inferred from its temporal response.	 55 the two wavelengths with group velocity dispersion correc-
Recorder. The data recorder 209 records the data measured	 tion 315.
by the demodulator. This data can be digitally processed to	 While directly generating the two frequencies and super-
produce an image that a human operator can interpret. 	 imposing them to produce beats is the most common way to
Each of these modules can be implemented in a variety of 	 stimulate CARS, this method has some disadvantages for the
different ways that can be tailored to various data acquisition 60 method of NIVI. In CARS and CSRS, there are two types of
needs. In addition, while these units are the basic units of the 	 generated signals. Resonant signals depend on the presence
invention, often the parts can be consolidated to simplify 	 of a molecule of a particular resonance frequency to be
implementation or reduce cost. While the basic block design 	 present to generate the CARS signal. Another component,
could be construed as that of a standard interferometric 	 nonresonant CARS, does not require a particular frequency to
microscope, nonlinear processes are occurring in the refer- 65 perform conversion. Nonresonant CARS depends on the peak
ence generator and "Microscope" sections that allow the reso- 	 intensity in the signal, while the resonant component can
nance information of the sample to be pumped. 	 build up from many beat periods and so therefore can be
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spread out in time. Because of this, it is advantageous to 	 tunately, while this wouldbe simpler, it modifies the spectrum
spread the CARS signals in time to reduce the nonresonant 	 of the pulse and therefore introduces artifacts into the NIVI
component.	 image.
However, when the two signals are discretely generated	 An alternative method is to take a pulse and impart a linear
and are transform-limited (are not chirped in time), the only 5 chirp to it. A linear chirp turns a pulse into one where the
way to broaden the signals in time is to reduce their band- 	 frequency rises or falls at a linear rate as a function of time.
width. To achieve sufficient power-spectral-density to cause 	 This rate is characterized by a constant a, which is the change
efficient conversion, the pulses must either generated by a 	 in frequency per unit time. It is called "chirped" because of
low-bandwidth laser, or much power will be wasted in filter- 	 the noise of the equivalent sound wave. If two copies of the
ing a higher bandwidth signal. Unfortunately, the range reso-  io chirped pulse are created, delayed with respect to each other
lution in OCT, when temporal ranging is used, is inversely 	 by imparting a variable time delay 407, and recombined, the
proportional to the illumination bandwidth. This requirement	 resulting pulse will have two simultaneous frequencies that
for high bandwidth conflicts with the requirement for small	 will rise or fall together at the same linear rate, but always be
bandwidth for resonance specificity. It would be desirable to 	 separated at a given instant by the same frequency. If this
come up with an alternate oscillator configuration that would 15 separation frequency is chosen to be Aw, then the envelope of
preserve the resonance specificity of the low bandwidth	 the pulse will be modulated by beats of this frequency. This
pulses, but actually utilize high bandwidth signals. 	 method is especially convenient because the probed reso-
Since the nonlinear excitation of the resonant molecule 	 nance frequency can be adjusted easily by adjusting the time
depends more on the beats produced than on the bandwidth
	
delay between the two chirped pulses, which is relatively easy
used to produce them, it would be desirable to take a broad- 20 and inexpensive. This will enable a NIVI instrument that can
band pulse and reshape it into a signal with the required beat 	 be rapidly and easily adjusted to scan a wide range of molecu-
frequency. Recent advancements have made pulsed sources 	 lar resonances. Systems based on tunable frequency sources
of very large bandwidth. Some of the methods to do this are 	 will likely be much more difficult to dynamically change
high-bandwidth Ti-sapphire oscillators, dispersion compen- 	 reliably and often.
sated mirror Ti-sapphire oscillators, double chirped-mirror 25	 The ability to linearly chirp a pulse is well known in the
Ti-sapphire oscillators, and continuum generation sources. 	 literature. It can be accomplished with a pulse shaper 405
The optical field produced by these sources can be shaped into 	 having a combination of prisms, diffraction gratings, lenses,
a field with the beats at the required frequency. 	 mirrors, and/or dispersive materials. Combinations may be
One such method that has been demonstrated in the litera- 	 required to ensure that the resulting chirp is linear and does
ture is shown in FIG. 4. A source of laser pulses from a laser so not contain significant amounts of higher-order dispersion.
source 401 is sent into a Fourier-plane pulse shaper 403 that 	 Higher-order dispersion would limit the resolution to which
utilizes a spatial-light-modulator (e.g. liquid crystal modula- 	 the resonance could be addressed and exclude other nearby
tor or acousto-optic modulator). The Fourier-plane pulse 	 frequency resonances. In a typical Chirped CARS NIVI setup
shaper enables each frequency in the pulse to have its phase 	 402, the chirp rate required would be fixed and the chirp rate
and/or amplitude altered. By applying the correct phase and 35 should need little or no adjustment in the field. Measuring
amplitude to each incoming frequency, the incoming signal
	
devices such as Frequency Resolved Optical Gating can test
can be convolved with an essentially arbitrary signal. The 	 whether a chirped pulse is linearly chirped.
pulse shaper is set up to reshape the incoming pulse by apply- 	 When using high-bandwidth excitation for CARS, it is
ing a period phase or amplitude perturbation in the Fourier 	 important to filter out the entire bandwidth of excitation
domain with period Aw/N, where N is a positive integer. This 4o before detection so it does not interfere with detection of the
will transform a single pulse into a train of pulses that are 	 emitted anti-Stokes light (Stokes for CSRS), because the
separated in time by 27t/Aw. If only a phase perturbation is 	 nonlinear emission can not be easily distinguished from the
used, the power of the signal canbe maximally preserved. The 	 much larger linearly scattered excitation light. However, this
larger the integer N is, the longer the pulse train will be, and
	
linearly scattered light contains the same structure that con-
none of the bandwidth of the original pulse will be lost. 45 ventional OCT imaging does, and may be used to measure
However, most pulse shapers have a limited number of con- 	 this information at the same time that a NIVI image is
trollable frequencies, limiting the practical size of N.	 recorded. This will be convenient for superimposing OCT
One advantage of spatial-light-modulator based pulse 	 and NIVI data onto the same image, because the acquisition
shapers is that there is typically a wide range of pulse shapes 	 of both types of data can be designed into the same instru-
that can be achieved, and the spatial-light-modulator can 50 ment. This can be implemented in practice by using a dichroic
often be controlled automatically by a computer. The com- 	 beamsplitter to separate the excitation and response radiation,
puter can then adjust the spatial-light-modulator to achieve	 and measuring the cross-correlation of the two frequency
maximum signal from the sample in a feedback loop. This 	 bands separately using a cross-correlation demodulator.
may allow automatic correction of dispersion or aberrations 	 With high-bandwidth sources where the entire bandwidth
introduced by the optics of the system, and will permit more 55 need not be utilized to produce the excitation field, it is
flexibility inprobing the molecule because of the tunability of 	 possible to use the upper end (for anti-Stokes) or lower end
the pulse shapes.	 (for Stokes) of this bandwidth as a reference field, eliminating
The pulse-shaper in the "Pulse-shaper type NIVI oscilla- 	 the need to separately generate a reference field. However, the
tor" 400 is well described in the literature. It consists of two	 frequencies of the reference must occupy the same band as the
diffraction gratings, which disperse and recombine the fre- 6o received CARS/CSRS light from the sample. Some sources,
quencies, two lenses that focus each frequency to a point and 	 especially continuum generation sources, will likely generate
recollimate each frequency, and a pulse shaper placed at the 	 much more bandwidth than needed for pulse shaping and
focal plane to separately operate on each frequency. The pulse 	 therefore will probably have this extra bandwidth available
shape is altered by dispersing each frequency to a separate 	 for this use. While a different process from CARS/CSRS
angle, and then imaging each frequency to a separate point on 65 typically generates this light, it will likely remain phase-
the spatial-light-modulator. Alternatively, an etalon may be 	 coherent with the CARS/CSRS light and therefore should be
used to shape the amplitude of the pulse periodically. Unfor-	 useful as a reference. Phase-coherence depends on the
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mechanism of pulse/continuum generation and therefore its	 verting them to the output signal using resonant CARS or
phase-coherence stability properties of a particular source	 CSRS. The magnitude of the cross-correlation between these
type must be established before it is suitable for this purpose.	 two signals should be great because of their similarity. In
A dichroic beamsplitter may be used to separate the fre-	 addition, if there is variability of oscillator output, having the
quency band corresponding to the response radiation from the 5 reference generator and sample contain the same substance
oscillator energy, so that it may be utilized as a reference 	 will respond in similar ways, so that the cross-correlation
signal.	 signal can remain high despite fluctuations in the oscillator.
It is also possible to simultaneously stimulate the excita- 	 The benefit of using the same molecule in the reference gen-
tion of several resonances if the sample is illuminated with the 	 erator is that it is the molecule's signal that acts as its own
appropriate pump and Stokes/anti-Stokes beams. For io "fingerprint" with which the cross-correlation can use to rec-
example, in CARS a narrowband pump signal and a wideband 	 ognize the molecule in the sample. If more selective excita-
Stokes can be used to address many resonances simulta- 	 tion processes than CARS are used, then using the same
neously. This is called multiplex CARS and can be extended 	 molecule in both reference and sample will help ensure that a
to CSRS with a broad anti-Stokes wavelength range. This	 reference signal can be generated for a given excitation field.
may be used to measure the presence of several molecular 15	 A nonresonant nonlinearity can be used as the reference
resonances simultaneously in the sample. In addition, if sev- 	 generator as long as the peak power of the oscillator signal
eral excitations can be produced in the same molecule simul- 	 can excite a sufficient quantity of reference signal. High peak
taneously, the molecule will evolve to various quantum states 	 power can be maintained by not chirping the oscillator signal
depending on the relative amplitude and timing between the 	 that is sent to the reference generator, while sending a rela-
CARS/CSRS stimulating signals for each resonance. This 20 tively low peak power signal to the sample. Nonresonant
may be produced by sending in multiple pairs of Stokes/anti- 	 CARS or CSRS can be used to generate an anti-Stokes or
Stokes wavelengths and pump beams in with varying time	 Stokes signal, respectively, from a medium that does not
delays between them. By varying the time delay between	 necessarily have a resonance at the frequency of the target
excitations, the molecule can be made to prefer Stokes or	 molecule. The benefit of this is that the medium may not have
anti-Stokes emissions from a particular quantum state. This 25 to be changed each time a different molecular species is
way, the amount of anti-Stokes radiation generated from each 	 scanned for, because otherwise a medium with a resonance at
quantum state could be potentially probed to identify the	 that wavelength would need to be chosen. Also, this species
molecule.	 can act as a standard signal source against which the return
In general, the spatial-light-modulator system of FIG. 4 	 signals from many samples can be compared. The nonreso-
could be used to produce more general pulse shapes than a 3o nant CARS can be implemented by focusing the excitation
series of beats at a single resonance frequency. By using a	 radiation into a sample of liquid that produces a CARS/CSRS
more complicated pulse shape, several bonds present in a	 signal in the same frequency band as that generated from the
molecule can be coherently excited, and energy transferred 	 sample. For example, benzene will generate a CARS anti-
between them in a coherent fashion. Because each molecule 	 Stokes signal in the 3000-3100 cm - ' frequency band.
has some difference between the bonds presents and their 35	 Continuum generation is another type of nonresonant non-
relative orientation (and therefore the coupling in the quan- 	 linear process that can be used in the reference generator. A
tum wave functions between them), pulses can be shaped that 	 sufficiently high peak power pulse is focused into a medium,
will selectively transfer energy between the states for a par- 	 where it excites a broad bandwidth of frequencies to be pro-
ticular molecule, and not be selective for other similar mol-	 duced. If the produced frequencies overlap the emission fre-
ecules. In this way, the emission of stimulated Raman scat- 4o quency band produced in the sample, this portion of the
tering or another coherent scattering process can be made 	 continuum can act as a reference signal. The generated con-
more specific than just every molecule possessing a bond of a 	 tinuum must be created by a mechanism that is sufficiently
particular energy. With an automatically controlled pulse 	 stable to not be overly sensitive to fluctuations in oscillator
shaper, such as those based on spatial light modulators, feed- 	 intensity. An unstable reference signal will result in noise in
back can be employed where the computer can test various 45 the cross-correlation signal. The benefit of continuum gen-
pulse shapes, measure the resulting emitted light temporal 	 eration is that is likely to create a broad bandwidth that will
signal using the demodulator, and progressive reshape the 	 have signal in the emission bandwidth of the sample, so that
pulse to optimize the signal from the target molecule and 	 the continuum need only be filtered for the needed frequency
exclude other molecules. Once a useful temporal field shape 	 band. Also, if the oscillator employs continuum generation, it
for stimulating a molecule has been found, it can be stored in 50 may already generate light within the emission bandwidth
a database and later used for identifying that molecule in the 	 that can be used as a reference generator, eliminating a sepa-
future.	 rate nonlinear process in the reference generator step. Some
2. Reference Generator.	 examples of materials used for continuum generation mate-
The reference generator takes a portion of the signal pro- 	 rials are optical glass, fused silica, calcium fluoride, sapphire,
duced by the oscillator and converts it to a reference signal. 55 ethylene glycol, water, high numerical aperture optical fibers,
This reference signal is later used to demodulate the sample 	 photonic crystal optical fibers, microstructured optical fibers,
signal. The reference generator is a nonlinear process that	 dispersion-shifted optical fibers, and gas cells (e.g. cells filled
converts light in the illumination bandwidth to light in the 	 with helium, argon, or nitrogen).
sample's emission bandwidth, so that interference can occur 	 Other candidate processes for nonresonant nonlinear ref-
between them. This nonlinear process may or may not be 60 erence generation include second and higher harmonic gen-
CARS or CSRS.	 eration, stimulated Raman scattering, sum and difference
A common implementation of the Reference Generator 	 frequency generation, optical parametric amplification, four-
would be to focus the oscillator excitation into a sample of the 	 wave mixing, and self phase modulation.
same molecular species that one wishes to image. The refer- 	 FIG. 5 shows an implementation of a reference signal
ence signal should then be very similar to the same molecular 65 generator 500. The concentration optics 503 are typically
species contained in the sample. This is because they are the 	 implemented as some combination of lenses and mirrors. The
same molecule, illuminated by nearly identical pulses, con-	 concentration optics may also require some combination of
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frequency dispersive elements such as prisms, diffraction
gratings, pulse shapers, and dispersive materials to prepare
the temporal shape of the signal for nonlinear generation.
Concentration in space and time may be necessary because
the nonlinear processes are power sensitive, and depends on
the strength of the nonlinear process. When the light 501
enters the nonlinear medium 505, it undergoes conversion to
a frequency band coinciding with the frequency band of the
response signal from the sample. This nonlinear medium may
be one of the media mentioned above, either a sample of a
target molecule, a solvent, or a continuum generation
medium. After exiting the nonlinear medium, the reference
signal 509 is collected by reference collection relay optics
507, where it is sent to the demodulator where it is combined
with the sample signal. The collection relay optics are usually
implemented as some combination of lenses and mirrors that
collimate the reference field radiation. This reference field
should be characterized to find its temporal structure by
instruments such as Frequency Resolved Optical Gating,
cross-correlation with another known signal, nonlinear sono-
grams, or nonlinear autocorrelations/cross-correlations.
3. Microscope.
The microscope delivers the excitation radiation from the
oscillator to the sample and collects the resulting sample
emission. Inside the sample, a coherent nonlinear process
such as CARS or CSRS takes place that, in the presence of a
molecule of interest, will emit the sample field in response to
the excitation field. The sample field is collectedby the micro-
scope and then propagated to the demodulator, where the
sample field can be estimated from the measured cross-cor-
relation between the sample field and reference field.
Microscope systems can be differentiated by various
implementation choices. They can either illuminate one (se-
rial scanning) or many points (full field imaging) at a time on
the tissue. If the pump and Stokes (anti-Stokes) beams of the
excitation field are separated in frequency, they can be sent in
either separate (non-collinear) or identical (collinear) angles
into the sample. The temporal delay of the response radiation
relative to the reference may or may not be used to range
molecular constituents in the tissue. The response radiation
can be collected in the forward scattering (forward CARS/
CSRS) or backward scattering (epi-CARS/CSRS) directions.
The microscope measures spatially resolved molecular
density by illuminating various points on the tissue with the
oscillator field, collecting the emitted sample field, and
recombining with the reference field in the demodulator. One
point in the tissue may be illuminated at a given time, result-
ing in serial or raster scanning of the molecular density
through the tissue. Alternatively, a line or a complete plane of
points may be illuminated, so that data may be acquired from
many points inparallel. Illuminating andmeasuring the radia-
tion from an entire plane of points is called full field imaging.
At the time of this writing, full field imaging is seldom used
because it requires an array intensity detector such as a
charge-coupled-device (CCD) to simultaneously measure the
demodulated signals of all of the illuminated points. Unfor-
tunately, as of this writing CCD arrays produce thermal dark
noise at each pixel, and also have a relatively limited dynamic
range of measurable intensity values. Demodulated interfer-
ence signals often require very high dynamic range detection.
It is conceivable that future CCD or other types of focal plane
arrays (e.g. CMOS arrays) may overcome these limitations.
Full field imaging also requires that the tissue be illuminated
by larger amounts of power because measurable signal must
be produced for an entire area rather than just one point. Since
14
this is more likely to result in tissue damage, full field imaging
will probably be used when speed of acquisition is para-
mount.
FIG. 6 shows three examples of full field CARS configu-
5 rations. The "beam delivery optics" are usually implemented
as some combination of mirrors and lenses that deliver beams
that illuminate a wide area or line on the sample. For all of
these microscope configurations, beam delivery and collec-
tion optics will typically utilize a microscope objective. The
io "response field collection optics" 601 are similarly imple-
mented as a combination of lenses and mirrors that relay the
response field to the demodulator so that it may be recom-
bined with the reference and detected. The noncollinear full
field CARS 602 delivers the pump 603 and the Stokes 605
15 beams (assuming they are separate) at separate angles, so that
the response is separated in angle from the illumination by an
angle given by phase-matching conditions. The collinear
geometry 607 sends the pump and Stokes radiation in the
same directions (or in a single field if they can not be sepa-
2o rated) and collects the radiation in the same direction, which
can be discriminated with a dichroic beamsplitter. The epi-
CARS geometry 611 collects the backscattered radiation,
usually through the same objective optics that the sample is
illuminated through. The epi-CARS can be discriminated
25 from the illumination with a dichroic beamsplitter or an inter-
ference filter.
If collinear CARS is used, where the pump and Stokes
(anti-Stokes) beams from the excitation beams overlap, then
the response field 609 will overlap the excitation beams. Then
30 the response field frequency band should not completely
overlap the excitation frequency band, so that a spectral filter
may distinguish between the excitation and response fields. If
non-collinear CARS is used, then the response beam can be
sufficiently angularly separated (as determined by the phase-
35 matching criterion) from the excitation radiation to be filtered
by a spatial filter. However, in the case of non-phase-matched
CARS, such as epi-CARS, the interaction CARS volume
must be small enough so that the response is radiated effec-
tively isotropically, so that spatial filtering is unavailable and
40 spectral filtering should be used.
The other, more commonly used alternative is serial point
scanning. Serial scanning tightly focuses the oscillation sig-
nal into the tissue to create a very small volume where peak
power is maximized. The focusing is usually achieved using
45 a microscope objective. This focus is then scanned through a
3-D set of points in the tissue, and the sample signal gathered
from each point is demodulated to produce a 3-D NIVI image.
Since nonlinear processes are power sensitive, efficient
CARS/CSRS occurs only at the focus. If the sample is small
50 enough, the focus may be scanned through the sample by
translating the sample in all three dimensions. However, it is
not feasible to move large samples such as human subjects
this way. In this case, the beam focus can be moved in the
transverse direction by steering the beam, perhaps using gal-
55 vanometer rotated mirrors, acousto-optic modulators, or
translating the lens assembly. The depth may be scanned by
mechanically adjusting the distance between the lens and the
tissue, perhaps using a lead-screw translator and/or a piezo-
electric transducer. Since the signal can be excited at only one
60 point at a time, one can be sure that the resulting measured
sample signal is due to the interference of emissions of radia-
tion produced in that volume only. This can be a benefit in
NIVI when high phase resolution is required because one is
assured that any measured phase shifts are not due to inter-
65 ference between molecules at disparate spatial locations. This
higher phase resolution may be used to better differentiate
between similar molecular species. Serial point scanning
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typically utilizes a single photodetector or a small number of 	 there are mechanisms for scanning the temporal delay much
photodetectors at the demodulator, which has the benefit that 	 faster than translating objective optics. The phase measure-
the dark current of a single photodetector is usually less than	 ment capability of NIVI is useful for both temporal ranging
that of an entire CCD array, and a single photodetector can 	 and molecular species identification this way.
also typically handle a higher dynamic range of measure- 5	 FIG. 9 shows two configurations of NIVI 900 and 902
ments.	 utilizing temporal ranging. Temporal ranging is achieved by
FIG. 7 shows the geometry of translated serial-port scan- 	 measuring the interference of the reference and response
ning configurations. In all of these configurations, the sample	 signals for various relative temporal delays. The temporal
is on a translator that moves the sample through the focus to 	 gating configuration superficially resembles the other epi-
form an image of the molecular density at various points. The io CARS configurations. However, unlike previous scanning
translator could be a three-axis linear screw drive translator, 	 modes, the depth-of-field of the focusing of the illumination
or piezoelectric translator, or a combination of these. The 	 from the beam delivery optics in the tissue is set to be long,
beam delivery optics 701 focuses the pump 703 and Stokes 	 because the temporal gating will be used to discriminate
(anti-Stokes) 705 beams onto the tissue at a point of interest, 	 between molecular constituents within the depth-of-field.
and the response field collection optics 707 gathers the gen- 15 This temporal ranging utilizes epi-CARS/epi-CSRS because
erated anti-Stokes (Stokes) field 709 from the tissue. In the 	 the backscattered response signal is collected from the
non-collinear geometry 700, the pump and Stokes illuminate	 sample by the response field connector so that the signal delay
the point of interest at different angles, so that the anti-Stokes 	 into the tissue can be timed. Because CARS/CSRS is not
will emerge at a third angle given by phase-matching, so that 	 phase-matched for the backwards direction, the generation of
the anti-Stokes is spatially separated from the illumination. In 20 a backscattered signal will only occur efficiently for small
the collinear geometry 702, the illumination and response 	 particles or edges of particles with a compatible resonance.
fields emerge overlapped, so that they must be discriminated	 The chief difference between this configuration and the other
by frequency (e.g. using a dichroic beamsplitter). Finally, in 	 epi-CARS configurations is that the interference signal is
the epi-CARS geometry 704, the backscattering response	 scanned as a function of relative delay, and an interference
fields are collected, often by the same optics through which 25 signal maximum indicates the presence of a molecular spe-
the illumination is projected, and can be separated with a 	 cies at a particular depth in the medium (corresponding to that
dichroic beamsplitter. 	 time delay). In the full field configuration 900, an entire plane
Alternatively, the focus can be moved and the sample can 	 of points is interfered with the reference signal to produce
be left stationary. This canbe accomplishedby a combination 	 simultaneous measurements of the cross-correlation signal
of tilting the illumination beams before it enters the beam so for the entire plane 909. By scanning the delay, the molecular
delivery optics and/or translating the beam delivery optics	 density of various planes can be measured. For the beam-
around (FIG. 8). Translating the collection optics and/or tilt- 	 steered temporal gating setup 902, the beam is scanned
ing the exiting response beam with a beam steering optics 801	 through the sample by tilting the beam through the beam
can capture the exiting response field. The beam steering 	 steering optics 903. Beam steering provides lateral displace-
optics changes the direction of the incoming beam 803. This 35 ment of the beam, and temporal gating provides depth infor-
can be implemented, for example, by a galvanometer-	 mation so that a three-dimensional volume is scanned. The
scanned rotating mirror. By changing the direction of the 	 sample can be translated laterally also to scan the beam. The
beam before it enters the beam delivery optics 809, the posi-	 implementation differences between the temporal gating con-
tion of the focus in the sample can be changed. The translation	 figurations are in the choice of depth-of-field of the illumina-
for the beam delivery and collection optics 807 can be imple- 40 tion and collection optics, and in the demodulator. The
mented with a piezoelectric and/or a linear screw-drive trans- 	 demodulator must be designed to scan a sufficient temporal
lation stage. Translating the beam delivery and/or collection	 interval to capture the interference signal between the refer-
optics moves the focus with the optics through the sample. 	 ence and response signals. This temporal interval is typically
These two mechanisms can be combined to enable the three- 	 between 500 microns to 10 mm.
dimensional translation of the focus through the sample. This 45	 4. Demodulator.
configuration is especially convenient for the epi-CARS con- 	 The purpose of the demodulator section is to decode the
figuration, because the same beam steering optics and beam	 response signal from the sample so that it may be measured by
delivery optics 809 can be used to collect the response field 	 relatively slow electronic equipment (slow compared to the
805. For these configurations, a compensating delay may 	 oscillations of the electric field of the response signal). The
need to be incorporated into the demodulator because steer- 50 magnitude of this demodulation signal will be related to the
ing the beam and/or translating the delivery and collection	 density of a molecular species of interest in the tissue. With
optics change the travel time for the illumination and
	
knowledge of the molecular density at eachpoint, a molecular
response signal through the microscope section.	 density map, or NIVI image, can bepresented to the user. This
All of the previous scanning modes, full field imaging,	 demodulation is implemented as the cross-correlation of the
translated serial-point scanning, and beam-steering serial- 55 response signal relative to a generated reference signal. Out-
port scanning, use the spatial location of the illumination	 lined below are various optical configurations that produce
beam to differentiate between response signal gathered from 	 this cross-correlation signal.
various points in the sample. This confinement method is the	 There are various design choices that are made when
same as that used by multiphoton microscopy or CARS 	 choosing a demodulator. First, one needs to know whether or
microscopy. Other technologies such as Optical Coherence 6o not full field microscopy is used. Also, one must decide
Tomography and Optical Coherence Microscopy use tempo-	 whether the cross-correlation will be measured one sample at
ral ranging in addition to spatial confinement to further isolate 	 a time, or many samples in a single instant.
the contributions of signal from various points in the sample. 	 FIG. 10 shows an example of a cross-correlator that can be
Because of the heterodyne nature of NIVI, this scanning 	 used to demodulate the full field CARS signal, measured for
mode is also available. It may be attractive for in vivo imaging 65 example as in FIG. 6. The response field is collected and
because it will enable scanning tissue without translating the 	 relayed by the "response field collection optics" of FIG. 6 to
microscope objective or sample, and may scan faster because	 the Response Field 1001 of FIG. 10. The reference field 1003
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is produced by the Reference Generator and relayed to the
cross-correlator. The reference is delayed relative to the
response field, and they are mutually overlapped using a
beamsplitter 1005. The "response field spectral filter" 1007
filters the recombined field for only the frequency band that
contains the response field bandwidth, which removes any
remaining oscillator signal. The filter can be implemented by
a combination of interference filters, color glass filters, dich-
roic beamsplitters, or other frequency selective elements. The
combined fields are imaged onto a focal plane array 1011,
such as a CCD, so that the CCD is the conjugate image plane
of the sample plane. The imaging is achieved with the "relay
imaging optics" 1009 which are some combination of lenses
and mirrors. The intensity detected on the CCD corresponds
to a single cross-correlation signal measurement collected
from various points in the sample. The "variable attenuator"
1013 is adjusted to maximize the use of the dynamic range of
intensity measurements of the CCD. As the focus in the
sample changes (e.g. by translating the sample), and/or the
adjustable delay 1015 is changed, the entire cross-correlation
signal canbe measured, forming a three-dimensional data set.
The typical scan range length for high numerical aperture full
field imaging will be up to 100 microns. The delay can be
implemented as a mirror translated by a linear-screw-drive
translation stage, or by piezoelectric actuation. This same
cross-correlation can also be used for temporal ranging full
field NIVI, as shown in FIG. 9, with the only difference being
that the delay mechanism must be designed to scan a suffi-
ciently long range of interest in the sample, typically from
500 microns to 10 mm.
The measurement of a cross-correlation signal for a serial-
point scanning microscope is basically the same system as for
full field imaging, except that a single photodetector can be
used rather than an array photodetector. The adjustable delay,
response field spectral filter, and relay imaging optics can all
be implemented in similar ways to the full field case. The
relay imaging optics will need only focus the combined
response/reference signal onto the photodetector. In some
cases, when only the magnitude of the cross-correlation sig-
nal at its peak needs to be measured, it may be desirable to
dither the adjustable delay with a piezoelectric transducer a
fraction of a wavelength, so that the magnitude of the cross-
correlation signal peak can be demodulation with a multiply-
ing mixer and low-pass filter (an electronic heterodyne
demodulator). This configuration will be covered in more
detail in part five. To measure the entire cross-correlation, the
adjustable delay will be scanned over various time delays and
the photodetector intensity signal measured.
In FIGS. 10 and 11, a variable attenuator 1013 is used to
adjust the intensity of the signal that reaches the photodetec-
tor 1101 so that its dynamic range is not exceeded. Variable
attenuators can be implemented with liquid crystal shutters,
neutral density filter wheels, or rotating polarizers. The spa-
tial filter 1103 is used on the response signal to filter out
spatial inhomogeneities in the response signal that could
reduce the depth of modulation at the photodetector. A spatial
filter would typically consist of a telescope of two converging
lenses, with a pinhole in the focal plane between the lenses to
filter out power around the main diffraction focus.
When the oscillator produces pulses of a low repetition
rate, so that for example high peak power can be employed,
one may want to measure multiple samples of the cross-
correlation signal simultaneously. This canbe achievedby the
configurations in FIG. 12. These configurations have the
advantage that, with a sufficient amount of pulse power and
number of photodetector array samples, the cross-correlation
signal can be measured using a single pulse. Low repetition
rate illumination can keep the peak power high while average
power remains low.
The "linear photodetector array cross-correlator" 1201
5 expands the response and reference signals, and interferes
them with an angle between the two beams. The beam expan-
sion is achieved by, for example, a pair of converging achro-
matic lenses 1203 arranged in a telescope configuration. The
points on the wavefront where the two signals combine will
io have various time delays between them. A cylindrical lens
1205 then focuses the beams into a line image on a linear
photodiode array 1207. This concentrates the signal to adjust
for the narrow height of the detector pixels. Each intensity
sample on the linear photodetector array indicates a sample of
15 cross-correlation of the two fields with various relative time
delays, with a constant intensity signal added. The recorder
would then read the linear CCD signal so that a complete
NIVI image can be assembled.
The primary disadvantage of this system is that the modu-
20 lation of the intensity signal on the linear photodetector array
is rather low, and the dynamic range of typical CCDs is
likewise low, so that the signal cannot be measured to a high
signal-to-noise ratio. To combat this, one can utilize the Fou-
rier-transform cross-correlator 1209. Rather than directly
25 measuring samples of the cross-correlation, it interferes the
two signals and measures their spectral decomposition. The
beamsplitter 1005 combines the response and reference sig-
nals, which are filtered for the response bandwidth by utiliz-
ing a response field spectral filter 1007. This signal is then
30 filtered by a frequency dispersive element 1211 such as a
diffraction grating that scatters each frequency to a different
angle. The power of each frequency is then focused to a
different pixel on the linear photodetector array 1215 by using
a focusing element 1213 (typically a combination of lenses or
35 mirrors). The samples of the intensity measured on the pho-
todetector indicate the real part of the Fourier transform of the
cross-correlation signal. The recorder may compute an
inverse discrete Fourier transform of the linear photodetector
array intensity samples to recover the cross-correlation. The
4o Fourier transform already performs the necessary Hilbert
transform to infer the imaginary part of the cross-correlation
signal. However, because it is an intensity measurement, the
cross-correlation signal, a time-reversed version, and the
autocorrelation of the response signal are superimposed in the
45 intensity signal. By choosing the adjustable delay longer than
the length of the cross-correlation temporal signal, the recon-
struction of these signal components will not overlap in the
time domain, and so the recorder device may distinguish the
cross-correlation from its mirror image and the autocorrela-
50 tion.
The adjustable delay may also be dithered a small amount
to introduce a phase shift into each measured frequency com-
ponent at the linear photodetector array. By utilizing at least
three linearly independent phase shifts, the phase of each
55 Fourier component can be known and the time domain cross-
correlation computed using an inverse discrete Fourier trans-
form. However, then the ability to measure the cross-correla-
tion of a single pulse will be lost. Another possibility is to use
a linear photodetector array with several rows (at least three)
6o rather than just one row of pixels. By tilting one of the wave-
fronts slightly vertically with respect to the other, a small
phase shift can be introduced in the measured cross-correla-
tion signal between rows on the linear photodetector. With a
sufficiently large phase shift, the complex amplitude of each
65 Fourier component can be inferred from the intensity samples
from each column on the linear photodetector by utilizing the
discrete Fourier transform. Since all of the time delayed
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cross-correlation samples are measured simultaneously, this
is a single-pulse measurement.
To minimize the effect of dark charge built up in the linear
CCD detector, it is best to discard the charge as soon as
possible before the pulse arrives, and read the CCD as soon as
possible after the pulse arrives. The speed of readout should
be as fast as possible given limitations in accuracy due to the
readout noise.
5. Record r.
The recorder accumulates the samples of the cross-corre-
lation signal gathered from various points in the sample,
processes this data, and presents these as a human-interpret-
able image. It is usually implemented as a data acquisition
digital computer with some method of automatic control of
the adjustable mechanisms (such as delay lines, piezoelectric
actuators, and galvanometer mirrors), analog-to-digital con-
version, and some form of image output device such as a
screen or printer. It may also have control of the oscillator
itself, to automatically tune the wavelengths or bandwidths of
output or control the rate or timing of pulse output. It may also
control the delay lines or spatial light modulators in the pulse
shaping mechanisms of FIG. 4.
Typically, the recorder will scan the illumination through
the sample and/or the adjustable time delay and measure the
cross-correlation signal. Unless the Fourier-Transform cross-
correlator is used, the intensity samples represent the cross-
correlation signal with a constant level added that could be
discarded. The magnitude of the cross-correlation signal indi-
cates the presence of the target molecular species. For CARS/
CSRS the magnitude of the cross-correlation signal is related
to the second power of the molecular density of that species.
By demodulating the magnitude of the cross-correlation sig-
nal, the molecular density can be estimated for the points on
the cross-correlation signal for the areas from which the
response signal was collected to form that cross-correlation
signal. Both spatial confinement and temporal ranging can be
used to differentiate between the signals due to molecular
densities at different locations in the sample.
FIG. 13 documents the relationship between the elements
of the recorder 1300. For serial-scanning or temporal-scan-
ning configurations, the instructions from the operator are
entered via a human interface device 1304 into the digital
computer 1301. The digital computer controls the scanned
beam position in the sample using the galvanometer mirror
angles of the galvanometer scanned mirrors 1303, the oscil-
lator 1302, the adjustable delay line 1309, the position of the
microscope objective position 1305, and/or the position of the
sample translator 1307 to scan the illumination through the
sample. In general only a subset of these need be controlled to
scan the three-dimensional volume of the tissue. If full field
imaging is used, usually only the depth and/or the delay line
need be scanned. The cross-correlation signal as measured by
the intensity is converted to a voltage by the photodetector
1311, which is in turn converted to a digital sample by the
analog-to-digital converter 1313. The digital computer varies
the delay line and/or reads various pixels from the photode-
tector (if it is an array detector) to determine the cross-corre-
lation signal. If a Fourier-transform cross-correlator is used,
the computer will need to compute the inverse discrete Fou-
rier transform of the signal to find its cross-correlation from
the intensity samples. The computer then associates the mag-
nitude of the cross-correlation signal with the molecular den-
sity, and assembles these magnitudes into a density map of the
sample. This density map is stored in the storage device 1312
presented on the visual display 1315 and/or made into a
physical representation with a printer or stereolithography
device 1317.
20
To aid in the measurement of the magnitude of the cross-
correlation signal, the configuration 1400 of FIG. 14 is sug-
gested.
Because the digital computer 1301 can record only rela-
y tively slow signals, a dither oscillator 1401 maybeusedto add
a small high-frequency dither signal into the adjustable delay
line 1309 that produces a periodic perturbation of the delay in
the signal of a magnitude usually of less than one wavelength.
This same signal is multiplied by the received photodetector
10 1403 interference signal to demodulate it, and is low pass
filtered throughthe low pass filters 1405 to remove harmonics
of the dither frequency. Both the dither and its quadrature
signal are demodulated, because these correspond to the real
and imaginary parts of the complex cross-correlation ampli-
15 tude. The analog-to-digital converter 1313 will then be
directly measuring a quantity proportional to the complex
magnitude of the cross-correlation for the delay line position.
The computer can utilize the digitized real and imaginary
cross-correlation components to display the amplitude and
20 phase of the cross-correlation signal. The amplitude will cor-
respond to the magnitude of the reflection, and the phase will
correspond to the Doppler shift of the reflection. If a very fast
dither signal is desired (above 10 kHz), an electro-optic
modulator or acoustical-optic modulator can be placed in the
25 adjustable delay line system to rapidly modulate the delay a
small amount.
The magnitude of the cross-correlation signal depends
both on the density of molecules available to produce the
response signal, and on the temporal structure of the signals
30 radiated from the molecules. The temporal signal produced
by the molecules can be inferred from the cross-correlation
signal. If f(t) is the temporal response signal produced by a
molecule, and g(t) is the known reference signal, the mea-
sured cross-correlation F(T) is given by:
35
F(T) 
_ E f(t)g(t -T) dt
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If F(w), G(w), and Qw) are the Fourier transforms of f(t),
g(t), and F(T) respectively, then I (w)=F(w)G(—w). The func-
tion F(w) can be computed from the Fourier transform of the
cross-correlation and G(w) can be computed from the mea-
45 sured reference signal. The Fourier transform F(w) oftempo-
ral signal f(t) can then be estimated by F(w)=I (w)G(—w) /(
6(— w)2+N(w)2) (change to equation), where N(w) is an esti-
mated power- spectral-density of the noise. An inverse Fourier
50 transform of F(w) yields f(t).
The recorder can perform this computation and thus
recover f(t) for various molecular species. An unknown mol-
ecule may be identified by comparing its temporal signal to
known molecular signals. In addition, by looking at the fre-
55 quencies w of phase arg F(w) where the phase changed rap-
idly, the resonance frequencies of the molecules of interest
can be determined to high precision. A library of the temporal
responses and resonance frequencies ofvarious molecules for
CARS excitation may be built up and used to identify
60 unknown molecules in vivo. We also note that the same cross-
correlation measurement configurations can be used to mea-
sure the OCT backscattered signal due to the scattering of the
excitation radiation. To do this, the excitation and response
bands should be separated with a dichroic beamsplitter, and
65 the cross-correlation setups implemented separately to elimi-
nate photon noise from the excitation band being measured in
the response band. Different cross-correlation setups may be
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Randomness introduced into the measurement process
may produce false positive indications of molecular densities,
or obscure weak concentrations of molecular densities. This
randomness has three sources: fluctuations in the oscillator,
vibrations and air currents, and noise introduced by the pho-
todetector.
Oscillator fluctuations are the hardest to characterize
because the feedback mechanism of laser sources can pro-
duce large variations in the frequency, bandwidth, and output
power of the pulses even for small perturbations of the oscil-
lator. In addition, nonlinear processes such as self-phase-
modulation, self-focusing (Kerr lensing), or continuum gen-
eration may also affect the pulse in ways that are sensitive to
the power in the pulse. Therefore, it is desirable to keep
fluctuations in pulse energy below a few percent, and keep
frequency and bandwidth fluctuations under one percent.
Well designed state-of-the-art Ti-sapphire oscillators and
regenerative amplifiers can meet these specifications if they
are aligned and maintained within the guidelines set up by the
manufacturer. It is important that the internals of the appara-
tus be shielded, as well as the paths of the beams, as much as
possible from air currents and vibrations. This can be
achieved by placing the apparatus on a platform with air
flotation or shock-mounted legs. The oscillator apparatus
should be enclosed in a rigid case with baffles that minimize
the opening surface area to thatrequired for thebeams to enter
and leave the case. It is best to use laser-diode or laser-diode-
pumped solid-state sources to pump the oscillator to mini-
mize pump fluctuations, but a well controlled ion laser is also
usable.
A dispersion compensated mirror Ti-sapphire system can
produce 200 nm or more bandwidth centered at 800 nm and is
also suitable for the chirped-CARS or CARS utilizing a pulse
shaper.
Another possibility is to employ a femtosecond diode-
pumped erbium or ytterbium fiber laser. Fiber-based con-
tinuum generation sources of nanojoule energy have been
demonstrated, and this source may be relatively inexpensive
and compact. A pulse selector ("pulse picker") utilizing a
Pockels cell or a fiber-based electro-optic modulator or elec-
tro-absorption modulator may be used to lower the average
power while keeping the peak power high. A fiber amplifier
can be used to increase the energy of the pulses. A fiber-based
amplifier may provide a more portable, stable source.
If continuum generation is used, a source employing self-
phase-modulation is preferable because of the short interac-
tion length of the nonlinearity. For example, a microjoule
energy pulse will broaden when focused into a fused silica,
sapphire, calcium fluoride, or quartz medium. Self-focusing
can be used to increase the peak power and minimize the
interaction length. Self-phase-modulation in an optical fiber
may be sufficient if it occurs over a short length of fiber. The
fiber should be single mode in the bandwidth utilized to
minimize nonlinear coupling of multiple modes. Higher peak
power allows a stronger nonlinearity to be used and therefore
minimizes the interaction length.
Photodetector noise is the other source of noise. There are
two sources of photodetector noise: photon noise and thermal
noise. Thermal noise may be eliminated by using a cooled
detector, or by minimizing the integration time. If a line
camera is used, the charge on the array can be expelled before
22
the pulse is received and the signal can be read out immedi-
ately after the pulse is received. Also, the reference power
should be balanced with the power received from the sample
so that the dynamic range of the detector is utilized. Photon
5 noise is fundamental to photodetection processes. Its effect
can be minimized in several ways: using more illumination
power to produce a larger CARS signal. Also, using the Fou-
rier-transform cross-correlator minimizes the photon noise
effect by increasing the modulation when single pulse illu-
io mination is used.
Equipment Brand Names:
Coherent Laser (of Coherent, Inc.) IOW Verdi pumps the
Kapteyn-Mumane Laboratories, LLC, titanium: sapphire
seed (pump) laser
15 Which pumps the
Coherent Regenerative Amplifier (RegA 9050)
And uses the
Coherent Stretcher/Compressor.
20	 A portion of the amplified light is sent to a
Coherent Optical Parametric Amplifier (OPA9450)
Which produces the second optical beam.
While we refer to a microscope (Leica) for beam delivery
and holding the sample, any standard optics could be used.
25 We are currently using a computer controlled 3-axis stage
(Newport Corp.) to translate our samples under the imaging
beams.
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50	 The invention claimed is:
1. A method of examining a sample, comprising:
exposing a non-linear reference medium to a first set of
electromagnetic radiation generated in an interferomet-
ric system to form a second set of electromagnetic radia-
55	 tion scattered from the non-linear reference medium;
exposing a sample to a third set of electromagnetic radia-
tion to form a fourth set of electromagnetic radiation
scattered from the sample; and interfering the second set
of electromagnetic radiation and the fourth set of elec-
60	 tromagnetic radiation; and
detecting fourth photos in the fourth set of electromagnetic
radiation;
wherein the detecting comprises interfering;
wherein the fourth photons are anti-Stokes photons or
65	 Stokes photons;
wherein the first set and the third set of electromagnetic
radiation are generated from a source;
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at least a portion of the second set of electromagnetic
radiation is of a frequency different from that of the first
set of electromagnetic radiation; and
at least a portion of the fourth set of electromagnetic radia-
tion is of a frequency different from that of the third set
of electromagnetic radiation.
2. The method of claim 1, wherein the fourth photons are
anti-Stokes photons.
3. The method of claim 1, wherein the fourth photons are
Stokes photons.
4.A method of forming an image of a sample, comprising:
exposing a non-linear reference medium to a first set of
electromagnetic radiation generated in an interferomet-
ric system to form a second set of electromagnetic radia-
tion scattered from the non-linear reference medium;
exposing a sample to a third set of electromagnetic radia-
tion to form a fourth set of electromagnetic radiation
scattered from the sample;
forming a digital data set corresponding to the sample; and
converting the data set into an image;
wherein the forming of the data set comprises interfering
the second set of electromagnetic radiation and the
fourth set of electromagnetic radiation;
the first set and the third set of electromagnetic radiation
are generated from a source;
at least a portion of the second set of electromagnetic
radiation is of a frequency different from that of the first
set of electromagnetic radiation; and
at least a portion of the fourth set of electromagnetic radia-
tion is of a frequency different from that of the third set
of electromagnetic radiation.
5. The method of claim 4, wherein the fourth photons are
anti-Stokes photons.
6. The method of claim 1, wherein the electromagnetic
radiation is in the frequency range of infra-red to ultraviolet
light.
7. The method of claim 4, wherein the electromagnetic
radiation is in the frequency range of infra-red to ultraviolet
light.
8. The method of claim 1, wherein the examining of the
sample is by optical coherence tomography.
9. The method of claim 4, wherein the forming of the data
set is by optical coherence tomography.
10. The method of claim 1, wherein the sample is selected
from the group consisting of a tissue sample, a single cell, and
a patient.
11. The method of claim 4, wherein the sample is selected
from the group consisting of a tissue sample, a single cell, and
a patient.
12. The method of claim 10, wherein the sample is a human
patient.
13. The method of claim 11, wherein the sample is a human
patient.
14. In a method of forming an image using an optical
coherence tomography, apparatus, the method including
exposing a sample or patient to electromagnetic radiation,
collecting scattered electromagnetic radiation, and forming
an image from the collected electromagnetic radiation includ-
ing interfering the collected electromagnetic radiation with
reference electromagnetic radiation, the improvement com-
prising the reference electromagnetic radiation being scat-
tered from a non-linear reference sample, and the wavelength
of the collected electromagnetic radiation being different
from that of the electromagnetic radiation that the sample or
patient is exposed to.
15. In an optical coherence tomography device, including
an electromagnetic radiation source for generating reference
26
electromagnetic radiation and sample electromagnetic radia-
tion, an optical delay line, a scanner, and a electromagnetic
radiation detector, the improvement comprising a reference
holder and optics adapted for exposing the reference electro-
5 magnetic radiation to a non-linear reference medium before
interfering the reference electromagnetic radiation with the
sample electromagnetic radiation.
16. A device for examining a sample, comprising:
an oscillator,
io	 a reference generator, including non-linear reference
medium, a optically coupled to the oscillator,
a sample illuminator, optically coupled to the oscillator,
an interferometric demodulator, optically coupled to the
reference generator and the sample illuminator,
15	 a recorder, coupled to the demodulator, and
a frequency-selecting element that ensures that the light
that illuminates the sample is excluded from the modu-
lator.
17. The device of claim 16, wherein the oscillator com-
20 prises a laser.
18. The device of claim 17, wherein the oscillator further
comprises a pulse shaper or a chirper.
19. The device of claim 16, further comprising a scanner
for scanning a sample, coupled to the sample illuminator.
25 20. A method of examining a sample, comprising:
exposing sample to a first set of electromagnetic radiation
generated in an interferometric system to form a second
set of electromagnetic radiation non-linearly scattered
from the sample; and
30	 interfering the second set of electromagnetic radiation with
a third set of electromagnetic radiation;
wherein the third set of electromagnetic radiation is coherent
with the first set of electromagnetic radiation;
at least a first portion of the second set of electromagnetic
35	 radiation is of a frequency different from that of the first
set of electromagnetic radiation; and
at least a portion of the third set of electromagnetic radia-
tion is of the same frequency as the first portion of the
second set of electromagnetic radiation.
40 21. The method of claim 20, further comprising detecting
second photons in the second set of electromagnetic radia-
tion; wherein the detecting comprises the interfering.
22. The method of claim 21, wherein the second photons
45 are anti-Stokes photons.
23.A method of forming an image of a sample, comprising:
exposing a sample to a first set of electromagnetic radiation
generated in an interferometric system to form a second
set of electromagnetic radiation non-linearly scattered
50	 from the sample;
forming a digital data set corresponding to the sample; and
converting the data set into an image;
wherein the forming of the image comprises interfering the
second set of electromagnetic radiation and a third set of
55 electromagnetic radiation;
wherein the third set of electromagnetic radiation is phase-
coherent with the first set of electromagnetic radiation;
at least a first portion of the second set of electromagnetic
radiation is of a frequency different from that of the first
60	 set of electromagnetic radiation; and
at least a portion of the third set of electromagnetic radia-
tion is of the same frequency as the first portion of the
second set of electromagnetic radiation.
24. The method of claim 23, further comprising detecting
65 second photons in the second set of electromagnetic radia-
tion; wherein the detecting comprises the interfering, and the
forming of the image comprises the detecting.
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25. The method of claim 23, wherein the second photons
are anti-Stokes photons.
26. The method of claim 23, wherein the second photons
are Stokes photons.
27. The method of claim 20, wherein the electromagnetic
radiation is in the frequency range of infra-red to ultraviolet
light.
28. The method of claim 23, wherein the electromagnetic
radiation is in the frequency range of infra-red to ultraviolet
light.
29. The method of claim 20, wherein the examining of the
sample is by optical coherence tomography.
30. The method of claim 23, wherein the forming of the
image is by optical coherence tomography.
31. The method of claim 20, wherein the sample is selected
from the group consisting of a tissue sample, a single cell, and
a patient.
32. The method of claim 23, wherein the sample is selected
from the group consisting of a tissue sample, a single cell, and
a patient.
33. The method of claim 31, wherein the sample is a human
patient.
28
34. The method of claim 32, wherein the sample is a human
patient.
35. A method of examining a sample, comprising:
exposing a non-linear reference medium to a first set of
5 electromagnetic radiation generated in an interferomet-
ric system to form a second set of electromagnetic radia-
tion inelastically scattered from the non-linear refer-
ence;
exposing a sample to a third set of electromagnetic radia-
io	 tion to form a fourth set of electromagnetic radiation
scattered from the sample; and
interfering the second set of electromagnetic radiation and
the fourth set of electromagnetic radiation;
wherein the first set and the third set of electromagnetic
15	 radiation are generated from a source;
at least a portion of the second set of electromagnetic
radiation is of a frequency different from that of the first
set of electromagnetic radiation; and
at least a portion of the fourth set of electromagnetic radia-
20	 tion is of a frequency different from that of the third set
of electromagnetic radiation.
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